|Articles|November 5, 2015

Pediatric Drug Development & Therapeutics

Author(s)DIA

DIA’s Editor-in-Chief Stephen P. Spielberg, MD, PhD, FAAP, and Ronald Portman, MD, FAAP, discuss the Pediatric Drug Development & Therapeutics series of articles and how they can help inform the future of pediatric drug development on DIA’s podcast channel, Driving Ideas to Action.

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Trending on PharmExec

Pediatric Drug Development & Therapeutics

Related Content

Pharmaceutical Executive Daily: Amplitude Therapeutics Partners with Eli Lilly

Your Questions Answered: What This Week's Rare Disease and Specialty Drug News Tells Us About Where the Industry Is Heading

Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb

The Shift Towards Globally Sourced Innovation

Why Dealmaking Is Now a Survival Skill: Q&A with Dan Chancellor

Trending on PharmExec

M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration

Pharmaceutical Executive Daily: Amplitude Therapeutics Partners with Eli Lilly

When Drug Pricing Becomes Trade Policy

Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb

FDA Approves Pasatru For Adults With Fibrodysplasia Ossificans Progressiva